| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… |
Trial sites expanded: 459 -> 475 locations |
| 2026-06-11 | NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… |
Trial sites expanded: 1152 -> 1155 locations |
| 2026-06-03 | NCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… |
Trial sites expanded: 452 -> 459 locations |
| 2026-06-03 | NCT06935370 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… |
Trial sites reduced: 639 -> 635 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06424288 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… | Heart Failure | Recruiting |
| NCT06935370 | A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… | Heart Failure | Recruiting |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… | Diabetes Mellitus, Type 2 | Recruiting |
| NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… | Kidney Disease, Chronic | Recruiting |
| Phase 2 | |||
| NCT06926660 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… | Chronic Kidney Disease | Active, Not Recruiting |
| Phase 1 | |||
| NCT07513207 | A Study in Healthy People to Test How Vicadrostat Affects the Heart | Healthy | Recruiting |